Predictive Factors for Infectious Complications after Robotic Gastrectomy for Gastric or Esophagogastric Junction Cancer
European Surgical Research · 2025
DOI: 10.1159/000549841 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Surgical Research, 2025. Verfasst von Sachiko Kaida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Shiga University of Medical Science, Shiga, Japan, kaida@belle.shiga-med.ac.jp. Hauptthemen laut MEDLINE: Stomach Neoplasms, Esophagogastric Junction, Esophageal Neoplasms, Gastrectomy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Robotic gastrectomy offers perioperative advantages such as reduced blood loss and faster recovery; however, infectious complications remain a significant concern. In this study, we aimed to identify the predictive factors for postoperative infectious complications following radical robotic gastrectomy in patients with gastric or esophagogastric junctional cancer.
Methods
This retrospective single-center study analyzed data from 155 patients with gastric or esophagogastric junction cancer who underwent curative robotic gastrectomy between December 2017 and April 2025 to identify predictive factors for postoperative infectious complications. Twenty-two variables, including nutritional indices and surgical factors, were evaluated.
Results
A total of 18 patients developed Clavien-Dindo grade II–IIIa infectious complications. Infectious complications included pneumonia (n = 5, 3.2%), intra-abdominal abscess (n = 5, 3.2%), anastomotic leakage (n = 3, 1.9%), cholecystitis (n = 2, 1.2%), nonocclusive mesenteric ischemia (n = 1, 0.6%), bile leakage (n = 1, 0.6%), and sepsis (n = 1, 0.6%). The number of patients with complications and American Society of Anesthesiologists Physical Status (ASA-PS) class ≥3 (p = 0.006) and preoperative smoking (p = 0.012) was higher than that among patients without complications. Although hemoglobin levels (p = 0.041) and lymphocyte-to-monocyte ratios (p = 0.017) were lower in patients with complications, the platelet-to-lymphocyte ratios (p = 0.034) were higher. Multivariate analysis revealed that current smoking (odds ratio, 3.21; 95% confidence interval, 1.24–18.21) and ASA-PS class of ≥3 (odds ratio, 3.8; 95% confidence interval, 1.18–7.52) were identified as predictors of infectious complications.
Conclusion
Robotic gastrectomy offers technical advantages, but optimizing patient-specific risk is essential for the best outcomes. Preoperative smoking and a high ASA-PS class were independent predictors of infectious complications following robotic gastrectomy. Enhanced perioperative management targeting these risk factors may reduce postoperative morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Shiga University of Medical Science, Shiga, Japan, kaida@belle.shiga-med.ac.jp.
- Department of Surgery, Shiga University of Medical Science, Shiga, Japan.
- Division of Nutrition Therapy, Shiga University of Medical Science Hospital, Shiga, Japan.
Zitieren
APA
Kaida, S., Takebayashi, K., Otake, R., Fukuo, A., Nitta, N., Mori, H., Maehira, H., Kojima, M., Miyake, T., & Tani, M. (2025). Predictive Factors for Infectious Complications after Robotic Gastrectomy for Gastric or Esophagogastric Junction Cancer. European Surgical Research. https://doi.org/10.1159/000549841
Vancouver
Kaida S, Takebayashi K, Otake R, Fukuo A, Nitta N, Mori H, et al. Predictive Factors for Infectious Complications after Robotic Gastrectomy for Gastric or Esophagogastric Junction Cancer. European Surgical Research. 2025. doi:10.1159/000549841
BibTeX
@article{Kaida2025,
author = {Kaida, Sachiko and Takebayashi, Katsushi and Otake, Reiko and Fukuo, Asuka and Nitta, Nobuhito and Mori, Haruki and Maehira, Hiromitsu and Kojima, Masatsugu and Miyake, Toru and Tani, Masaji},
title = {Predictive Factors for Infectious Complications after Robotic Gastrectomy for Gastric or Esophagogastric Junction Cancer},
journal = {European Surgical Research},
year = {2025},
doi = {10.1159/000549841}
}
EUVIMED